You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
This story was originally posted on May 17.
Lineagen plans to launch an upgraded version of its FirstStepDx test for autism spectrum disorders.
By a GenomeWeb staff reporter
By Adam Bonislawski
A team led by Uppsala University and Linnaeus University researchers has identified a trio of peptides in plasma that could prove useful biomarkers for autism.
By Justin Petrone
By Andrea Anderson
By Monica Heger
By Molika Ashford
Cleveland Clinic researchers have launched a 600-patient prospective study evaluating a SNP panel for predicting autism risk developed by French biotech firm IntegraGen.
By Bernadette Toner
GenomeQuest this week said that the Emory Genetics Laboratory is using its GQ-Dx software to support a suite of sequencing-based diagnostic tests it offers through its CLIA-certified facility.
The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.
NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.
Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.
In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.